8 completed. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 8 |
Follow ESRD: new trials by email Literature Review of ESRD trials Research Report on ESRD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis Fexofenadine, Gabapentin - Uremic Pruritus, Chronic Kidney Disease-associated Pruritus | Phase 4 | Completed | Tanta University | 60 | 2024-07-01 | 2025-04-27 |
| Safety and Efficacy of Canagliflozin in Advanced CKD Invokana 300 mg and 100 mg tablet - ESRD, CKD Stage 4 | Phase 4 | Completed | McGill University Health Centre/Research Institute of the McGill University Health Centre | 34 | 2022-11-24 | 2026-07-13 |
| Pharmacokinetics of JULUCA in Hemodialysis JULUCA 50Mg-25Mg Tablet - HIV/AIDS, ESRD | Phase 4 | Completed | Indiana University | 8 | 2021-04-23 | 2024-06-05 |
| Phosphate Kinetic Modeling 2 PKM Algorithm - Hyperphosphatemia, ESRD | Phase 4 | Completed | Fresenius Medical Care North America | 81 | 2010-09-01 | 2014-08-18 |
| The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition double-chamber bag Stay-Safe Balance system, glucose-based dialysis solution - Renal Failure, ESRD | Phase 4 | Completed | Chinese University of Hong Kong | 68 | 2010-09-01 | 2014-09-08 |
| IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients Physioneal, Dianeal, Extraneal - ESRD, Diabetes | Phase 4 | Completed | Vantive Health LLC | 137 | 2008-01-01 | 2025-07-22 |
| Donor Dopamine and Initial Graft Function Dopamine infusion to brain dead organ donors - Kidney Transplantation, ESRD | Phase 4 | Completed | Universitätsmedizin Mannheim | 487 | 2004-03-01 | 2009-04-23 |
| Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia Gentamycin/citrate, Minocycline/EDTA - ESRD | Phase 4 | Completed | Henry Ford Health System | 120 | 2003-09-01 | 2006-02-22 |
Kidney Failure, Chronic (8) · Acquired Immunodeficiency Syndrome (1) · Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Hyperphosphatemia (1) · Malnutrition (1) · Pruritus (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
Chronic Disease (8) · Disease Attributes (8) · Female Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (8) · Kidney Diseases (8) · Male Urogenital Diseases (8) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Urogenital Diseases (8) · Urologic Diseases (8) · Renal Insufficiency (7) · Renal Insufficiency, Chronic (7) · Nutritional and Metabolic Diseases (3) · Metabolic Diseases (2) · Blood-Borne Infections (1)
Canagliflozin (1) · Citric Acid (1) · Gabapentin (1) · Gentamicins (1) · Icodextrin (1) · Nutrineal (1) · Tablets (1) · dolutegravir, rilpivirine drug combination (1) · fexofenadine (1)
Chinese University of Hong Kong (1) · Fresenius Medical Care North America (1) · Henry Ford Health System (1) · Indiana University (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Tanta University (1) · Universitätsmedizin Mannheim (1) · Vantive Health LLC (1)
United States (3) · Hong Kong (2) · Canada (1) · Egypt (1) · Germany (1) · Russia (1) · Singapore (1) · South Korea (1) · Taiwan (1)
Ahmed M Hussein, PhD (1) · Antanole Bearabe, MD (1) · Cheuk Chun Szeto, MD (1) · Detlef Boesebeck, MD (1) · Mohamed I Hosney, PharmD (1) · Peter Kotanko, MD (1) · Peter Schnuelle, MD (1) · Philip KT Li, MD (1) · Sahar M El-Haggar, PhD (1) · Samir K Gupta, MD (1) · Thomas Mavrakanas, MD (1) · Werner Lauchart, MD (1)
PMID 12138146, PMID 15492943, PMID 19738091, PMID 21996389, PMID 22067309, PMID 26510186, PMID 28213388, PMID 29027352, PMID 29994980, PMID 30102825, PMID 39430196, PMID 39761595, PMID 40952584